CN1342078A - 3－异噁唑烷酮及羟氨酸用于治疗感染的用途 - Google Patents

3－异噁唑烷酮及羟氨酸用于治疗感染的用途 Download PDF

Info

Publication number
CN1342078A
CN1342078A CN00802779A CN00802779A CN1342078A CN 1342078 A CN1342078 A CN 1342078A CN 00802779 A CN00802779 A CN 00802779A CN 00802779 A CN00802779 A CN 00802779A CN 1342078 A CN1342078 A CN 1342078A
Authority
CN
China
Prior art keywords
methyl
dimethyl
chlorophenyl
chloro
isoxazolidinone
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
CN00802779A
Other languages
English (en)
Chinese (zh)
Inventor
哈桑·朱马
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Jomaa Pharmaka GmbH
Original Assignee
Jomaa Pharmaka GmbH
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from DE19903666A external-priority patent/DE19903666A1/de
Application filed by Jomaa Pharmaka GmbH filed Critical Jomaa Pharmaka GmbH
Publication of CN1342078A publication Critical patent/CN1342078A/zh
Pending legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/16—Amides, e.g. hydroxamic acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/16—Amides, e.g. hydroxamic acids
    • A61K31/164—Amides, e.g. hydroxamic acids of a carboxylic acid with an aminoalcohol, e.g. ceramides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/16—Amides, e.g. hydroxamic acids
    • A61K31/165—Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/42—Oxazoles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/10—Antimycotics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00—Antiparasitic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00—Antiparasitic agents
    • A61P33/02—Antiprotozoals, e.g. for leishmaniasis, trichomoniasis, toxoplasmosis
    • A61P33/06—Antimalarials
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Epidemiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
CN00802779A 1999-01-13 2000-01-12 3－异噁唑烷酮及羟氨酸用于治疗感染的用途 Pending CN1342078A (zh)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
DE19900907 1999-01-13
DE19900907.4 1999-01-13
DE19903666.7 1999-01-30
DE19903666A DE19903666A1 (de) 1999-01-13 1999-01-30 Arzneimittel mit einem Gehalt an 3-Isoxazolidinonen und Hydroxylaminsäuren als Wirkstoff und ihre Verwendung

Publications (1)

Publication Number Publication Date
CN1342078A true CN1342078A (zh) 2002-03-27

Family

ID=26051290

Family Applications (1)

Application Number Title Priority Date Filing Date
CN00802779A Pending CN1342078A (zh) 1999-01-13 2000-01-12 3－异噁唑烷酮及羟氨酸用于治疗感染的用途

Country Status (14)

Country Link
EP (1) EP1143941A3 (fr)
JP (1) JP2002534440A (fr)
CN (1) CN1342078A (fr)
AU (1) AU2436600A (fr)
BR (1) BR0007491A (fr)
CA (1) CA2360366A1 (fr)
CZ (1) CZ20012380A3 (fr)
HU (1) HUP0105412A2 (fr)
IL (1) IL143795A0 (fr)
NO (1) NO20013464L (fr)
PL (1) PL350128A1 (fr)
SK (1) SK9502001A3 (fr)
TR (1) TR200102019T2 (fr)
WO (1) WO2000041473A2 (fr)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1443930A1 (fr) 2001-10-25 2004-08-11 AstraZeneca AB Derives d'isoxazoline utilises en tant qu'agents antimicrobiens
GB202209172D0 (en) * 2022-06-22 2022-08-10 Syngenta Crop Protection Ag Improvements in or relating to organic compounds

Family Cites Families (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IL45174A (en) * 1973-08-10 1976-12-31 Merck & Co Inc Antibacterial preparations containing a compound of the type 3-fluoro-D-alanine and a cyclocarrin compound that is converted in the nitrogen atom
US3911007A (en) * 1974-08-08 1975-10-07 Searle & Co N-substituted N-benzyloxy-2-methyl-2-(4-halophenoxy)propionamides
FR2290442A1 (fr) * 1974-11-06 1976-06-04 Aries Robert Nouvelles rifamycines
EP0219923B1 (fr) * 1985-04-30 1992-09-02 Takeda Chemical Industries, Ltd. Dérivés antibiotiques, leur préparation et leur application
GB8531838D0 (en) * 1985-12-30 1986-02-05 Wellcome Found Aryl derivatives
JPS63119476A (ja) * 1986-11-05 1988-05-24 Takeda Chem Ind Ltd イソキサゾリドン誘導体
JPS63119462A (ja) * 1986-11-05 1988-05-24 Takeda Chem Ind Ltd 五員環ｎ−スルホ化合物
US5288896A (en) * 1992-01-15 1994-02-22 Warner-Lambert Company 3,5-di-t-butyl-4-hydroxylphenylmethylhydroxylamines and their derivatives, pharmaceutical compositions, and methods of use therefor
EP0689538B1 (fr) * 1993-03-16 1998-08-12 British Biotech Pharmaceuticals Limited Derives d'acide hydroxamique utilises comme inhibiteurs de metalloproteinase
EP0715619A4 (fr) * 1993-08-23 1997-03-19 Immunex Corp Inhibiteurs de la secretion de facteur alpha de necrose tumorale
GB9401129D0 (en) * 1994-01-21 1994-03-16 British Bio Technology Hydroxamic acid derivatives as metalloproteinase inhibitors
WO1996013263A2 (fr) * 1994-11-01 1996-05-09 Research Corporation Technologies, Inc. Methodes de traitement de maladies virales par des inhibiteurs de la biosynthese des sphingolipides
US5919790A (en) * 1996-10-11 1999-07-06 Warner-Lambert Company Hydroxamate inhibitors of interleukin-1β converting enzyme
US6251913B1 (en) * 1997-03-28 2001-06-26 Zeneca Limited Hydroxamic acids substituted by heterocycles useful for inhibition of tumor necrosis factor
AUPO721997A0 (en) * 1997-06-06 1997-07-03 Queensland Institute Of Medical Research, The Anticancer compounds

Also Published As

Publication number Publication date
AU2436600A (en) 2000-08-01
WO2000041473A2 (fr) 2000-07-20
IL143795A0 (en) 2002-04-21
PL350128A1 (en) 2002-11-04
JP2002534440A (ja) 2002-10-15
EP1143941A3 (fr) 2002-02-06
SK9502001A3 (en) 2002-05-09
TR200102019T2 (tr) 2002-04-22
BR0007491A (pt) 2001-11-20
EP1143941A2 (fr) 2001-10-17
NO20013464D0 (no) 2001-07-12
CA2360366A1 (fr) 2000-07-20
WO2000041473A3 (fr) 2001-11-29
NO20013464L (no) 2001-09-12
HUP0105412A2 (hu) 2002-05-29
CZ20012380A3 (cs) 2002-01-16

Similar Documents

Publication Publication Date Title
RU2675360C2 (ru) Способы лечения местных микробных инфекций
RU2607660C2 (ru) Композиция, содержащая антибиотик и диспергирующее средство или антиадгезивный агент
AU2014214548B2 (en) Methods of treating microbial infections, including mastitis
CN114126606B (zh) 分散包含革兰氏阴性菌的生物膜的方法
CN109475515A (zh) 抗菌组合物
CN1328465A (zh) 膦酰基甲酸衍生物治疗感染的用途
KR20220154142A (ko) 생물막 형성 방해 및 생물막 관련 질환 치료용 조성물
US10065978B2 (en) Cysteine-modifying substrate analogue inhibitors of ribose 5-phosphate isomerase for parasitic diseases, along with methods of their formation and use
JPH07188030A (ja) 薬剤の製造のためのモエノマイシンおよびその誘導体並びにこれらを含有する薬剤
CN1337881A (zh) 有机磷化合物预防或治疗感染的应用
CN1342078A (zh) 3－异噁唑烷酮及羟氨酸用于治疗感染的用途
CN1319006A (zh) 有机磷化合物在制备用于治疗或预防性治疗感染的药物或者在植物中作为杀真菌剂、杀菌剂或除草剂的用途
CN1285745A (zh) 酶前体药物作为抗感染剂的应用
Rosenberg et al. Antibiotic TA: an adherent antibiotic
CN1328464A (zh) 膦酰基甲酸衍生物在治疗感染中的应用
RU2713154C1 (ru) Антихеликобактерное средство и способ его применения
Wang et al. Recent Advances in Bacterial Biofilm Studies: Formation, Regulation, and Eradication in Human Infections
ZA200105007B (en) Use of 3-isoxazolidinones and hydroxylamine acids for the treatment of infections.
WO2024158908A1 (fr) Méthodes de traitement d'infections bactériennes
JP4081157B2 (ja) ヘリコバクター・ピロリ菌用抗菌剤
KR20170132566A (ko) 항생제의 서방형 수의학적 조성물 및 이의 제조방법
BG64765B1 (bg) 8а-азалиди като ветеринарни противомикробни средства

Legal Events

Date Code Title Description
C10 Entry into substantive examination
SE01 Entry into force of request for substantive examination
C06 Publication
PB01 Publication
C02 Deemed withdrawal of patent application after publication (patent law 2001)
WD01 Invention patent application deemed withdrawn after publication